AADI
Income statement / Annual
Last year (2023), Aadi Bioscience, Inc.'s total revenue was $24.35 M,
an increase of 60.06% from the previous year.
In 2023, Aadi Bioscience, Inc.'s net income was -$65.77 M.
See Aadi Bioscience, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$24.35 M
|
$15.22 M
|
$1.00 M
|
$14.00 M
|
$749,000.00
|
$20.16 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$2.81 M |
$1.34 M |
$276,000.00 |
$176,000.00 |
$76,501.00 |
$0.00 |
$51,268.00 |
$69,673.00 |
$57,977.00 |
$23,972.00 |
| Gross Profit |
$21.55 M |
$13.88 M |
$724,000.00 |
$13.82 M |
$672,499.00 |
$20.16 M |
-$51,268.00 |
-$69,673.00 |
-$57,977.00 |
-$23,972.00 |
| Gross Profit Ratio |
0.88 |
0.91 |
0.72 |
0.99 |
0.9 |
1 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$48.93 M
|
$32.66 M
|
$19.67 M
|
$15.01 M
|
$12.82 M
|
$17.85 M
|
$12.15 M
|
$11.37 M
|
$11.63 M
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$18.51 M
|
$2.12 M
|
$1.85 M
|
$13.49 M
|
$9.24 M
|
$29,492.00
|
$23,006.00
|
$22,824.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.83 M
|
-$46,686.00
|
-$51,268.00
|
$5.17 M
|
$5.78 M
|
$0.00
|
| Selling, General &
Administrative Expenses |
$44.55 M
|
$40.18 M
|
$18.51 M
|
$2.12 M
|
$9.68 M
|
$13.44 M
|
$9.19 M
|
$5.20 M
|
$5.80 M
|
$22,824.00
|
| Other Expenses |
$0.00 |
$5.06 M |
-$120,000.00 |
-$580,000.00 |
-$142,729.00 |
-$6,394.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$93.48 M |
$72.84 M |
$38.06 M |
$16.55 M |
$22.50 M |
$31.29 M |
$21.34 M |
$16.56 M |
$17.43 M |
$22,824.00 |
| Cost And Expenses |
$96.29 M |
$74.17 M |
$38.06 M |
$16.55 M |
$22.58 M |
$31.34 M |
$21.39 M |
$16.63 M |
$17.49 M |
$22,824.00 |
| Interest Income |
$6.40 M |
$2.40 M |
$13,000.00 |
$41,000.00 |
$1.03 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$231,000.00 |
$230,000.00 |
$665,000.00 |
$815,000.00 |
$0.00 |
$778,215.00 |
-$105,782.00 |
$9,942.00 |
$8,434.00 |
$5,877.00 |
| Depreciation &
Amortization |
$169,000.00
|
$159,000.00
|
$276,000.00
|
$176,000.00
|
$76,501.00
|
$46,686.00
|
$51,268.00
|
$69,673.00
|
$57,977.00
|
$0.00
|
| EBITDA |
-$65.37 M
|
-$60.12 M
|
-$109.15 M
|
-$2.49 M
|
-$24.44 M
|
-$10.35 M
|
-$21.24 M
|
-$16.43 M
|
-$17.01 M
|
-$22,824.00
|
| EBITDA Ratio |
-2.68 |
-3.72 |
-35.46 |
-0.19 |
-30.05 |
-0.55 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-2.95
|
-3.87
|
-111.22
|
-0.18
|
-30.15
|
-0.55
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$6.17 M
|
$2.17 M
|
$1.13 M
|
-$927,000.00
|
$1.17 M
|
$784,605.00
|
-$12,066.00
|
-$349,926.00
|
$416,332.00
|
$17,145.00
|
| Income Before Tax |
-$65.77 M |
-$60.51 M |
-$110.09 M |
-$3.48 M |
-$23.27 M |
-$10.40 M |
-$21.40 M |
-$16.98 M |
-$17.07 M |
-$28,701.00 |
| Income Before Tax Ratio
|
-2.7
|
-3.98
|
-110.09
|
-0.25
|
-31.07
|
-0.52
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$3.50 M |
$2,000.00 |
$2,000.00 |
$1,300.00 |
$778,215.00 |
-$12,063.00 |
-$3.00 |
$3.00 |
$0.00 |
| Net Income |
-$65.77 M |
-$57.01 M |
-$110.09 M |
-$3.48 M |
-$23.27 M |
-$10.40 M |
-$21.40 M |
-$16.98 M |
-$17.07 M |
-$28,701.00 |
| Net Income Ratio |
-2.7 |
-3.75 |
-110.09 |
-0.25 |
-31.07 |
-0.52 |
0 |
0 |
0 |
0 |
| EPS |
-2.44 |
-2.53 |
-12.34 |
-20.52 |
-8.6 |
-4.6 |
-14.81 |
-9.42 |
-9.47 |
-0.0159 |
| EPS Diluted |
-2.44 |
-2.53 |
-12.34 |
-20.52 |
-8.6 |
-4.6 |
-14.81 |
-9.42 |
-9.47 |
-0.0159 |
| Weighted Average Shares
Out |
$26.92 M
|
$22.51 M
|
$8.92 M
|
$169,490.00
|
$2.71 M
|
$2.26 M
|
$1.44 M
|
$1.80 M
|
$1.80 M
|
$1.80 M
|
| Weighted Average Shares
Out Diluted |
$26.92 M
|
$22.51 M
|
$8.92 M
|
$169,490.00
|
$2.71 M
|
$2.26 M
|
$1.44 M
|
$1.80 M
|
$1.80 M
|
$1.80 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
